Designed for quick, everyday reference, Handbook of Targeted Cancer
Therapy and Immunotherapy, 3rd Edition, includes clinical trial results
of more than 250 state-of-the-art targeted therapy and immunotherapy
agents, providing a practical, intuitive, colorful overview of this
rapidly advancing field. Comprehensive yet concise, this easy-access
resource by Drs. Daniel D. Karp, Gerald S. Falchook, and JoAnn D. Lim,
helps you navigate through the newest research reports and apply the
most recent discoveries as they pertain to specific tumor types,
actionable molecular targets, and clinical performance of
investigational targeted agents and combinations of agents. This
handbook presents information distilled by dozens of translational
research clinicians and other healthcare experts with hundreds of years
of cumulative experience in the revolutionary area of genomically based
precision oncology.
-
Covers cancer targets--phase 1, 2, and 3 trials and preliminary
results, as well as approved therapies.
-
Includes sections on Molecular Targets and Pathways, and Targeted and
Immunotherapy Agents.
-
Contains a section on Carcinogenesis from the Perspective of Targeted
Therapy and Immunotherapy, with essential content on biology,
immunology, and immunotherapy.
-
Organizes information by tumor type, pathway, and drug name, so you
can approach clinical challenges from any direction.
-
Highlights FDA approvals throughout.
-
Pocket-sized and color coded to help you find information quickly and
easily.
Enrich Your eBook Reading Experience
-
Read directly on your preferred device(s), such as computer, tablet,
or smartphone.
-
Easily convert to audiobook, powering your content with natural
language text-to-speech.
